u 69593 has been researched along with oxymorphone in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Borsodi, A; Hosztafi, S; Nevin, ST; Rónai, AZ; Spetea, M; Tóth, G | 1 |
Clot-Faybesse, O; Devaux, C; Guieu, R; Halimi, G; Legof, L; Rochat, H; Sampol, J | 1 |
2 other study(ies) available for u 69593 and oxymorphone
Article | Year |
---|---|
Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids.
Topics: Animals; Benzeneacetamides; Benzofurans; Binding, Competitive; Brain; Cell Membrane; Enkephalin, Ala(2)-MePhe(4)-Gly(5)-; Enkephalin, D-Penicillamine (2,5)-; Enkephalins; Naloxone; Naltrexone; Oligopeptides; Oxycodone; Oxymorphone; Pyrrolidines; Radioligand Assay; Rats; Rats, Wistar; Receptors, Opioid, delta; Receptors, Opioid, mu; Tritium | 1998 |
Modulation of adenosine concentration by opioid receptor agonists in rat striatum.
Topics: Adenosine; Animals; Benzamides; Benzeneacetamides; Binding, Competitive; Corpus Striatum; Female; Injections, Intraperitoneal; Oxymorphone; Phenethylamines; Piperazines; Purinergic P1 Receptor Agonists; Pyrrolidines; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2A; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Purinergic P1; RNA, Messenger | 2000 |